LYSAKER, Norway (December 6, 2005) - A randomized, double-blind, dose-ranging, non-placebo controlled pilot trial, conducted by researchers at the University of Arizona College of Medicine(Acta Psychiatr Scand 2005: 1-5) used EPAX Omega-3 oil to analyze the effect of omega-3 fatty acid consumption on postpartum depression.

The research indicated that scores on depression measures decreased by approximately 50 percent, and were statistically significant. Additional clinical research is currently underway.

Internet Resources:
EPAX Press Release on NPIcenter
Abstract

NPRI's Patented O2P Oil Powdering Process ensures Oil conversion to powder without affecting the isomers of the oil. Factors that DO affect the original oil profile are pressure, heat or extreme cold. These powdering techniques are NOT used by NPRI! You can rest assured that your customers are getting the purest, highest quality Oil Powder there is.

When developing or re-engineering your products containing omega-3 fatty acids, consider O2P Omega-3 Powders!